Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.

Kako S, Nakasone H, Endo H, Sakamoto K, Ashizawa M, Sato M, Terasako K, Kikuchi M, Kimura S, Okuda S, Yamazaki R, Oshima K, Tanihara A, Nishida J, Usuki K, Kanda Y.

Hematol Oncol. 2012 Jun;30(2):82-8. doi: 10.1002/hon.1001. Epub 2011 Jun 21.

PMID:
21692099
2.

Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).

Koh Y, Lee HR, Song EY, Kim HK, Kim I, Park S, Park MH, Kim BK, Yoon SS, Lee DS.

Leuk Res. 2010 Oct;34(10):1344-50. doi: 10.1016/j.leukres.2010.03.001. Epub 2010 Apr 27.

PMID:
20427085
3.

The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome.

Cordoba I, Gonzalez-Porras JR, Such E, Nomdedeu B, Luño E, de Paz R, Carbonell F, Vallespi T, Ardanaz M, Ramos F, Marco V, Bonanad S, Sanchez-Barba M, Costa D, Bernal T, Sanz GF, Cañizo MC.

Leuk Res. 2012 Mar;36(3):287-92. doi: 10.1016/j.leukres.2011.10.025. Epub 2011 Nov 30.

PMID:
22133642
4.

Infection in the myelodysplastic syndromes.

Pomeroy C, Oken MM, Rydell RE, Filice GA.

Am J Med. 1991 Mar;90(3):338-44.

PMID:
2003516
5.

[Long-term follow-up of malignant clonal evolution in patients with acquired aplastic anemia].

Li XX, Ge ML, Shi J, Feng XY, Shao YQ, Qian LS, Zheng YZ.

Zhonghua Xue Ye Xue Za Zhi. 2011 Jul;32(7):463-7. Chinese.

PMID:
22213866
6.

Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.

Li Y, Li X, Ge M, Shi J, Qian L, Zheng Y, Wang J.

Ann Hematol. 2011 May;90(5):529-37. doi: 10.1007/s00277-010-1140-9. Epub 2011 Jan 5.

PMID:
21207031
7.

Clinical course of non-severe aplastic anemia in adults.

Kwon JH, Kim I, Lee YG, Koh Y, Park HC, Song EY, Kim HK, Yoon SS, Lee DS, Park SS, Shin HY, Park S, Park MH, Ahn HS, Kim BK.

Int J Hematol. 2010 Jun;91(5):770-5. doi: 10.1007/s12185-010-0601-1. Epub 2010 Jun 5.

PMID:
20524094
8.

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.

Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, Yoon SS, Park SY, Kim BK, Suh C, Son HJ, Jung CW, Lee JH, Sung JM, Im SA, Oh D, Jung SY, Yoon HJ, Cho KS, Lee JA, Yuh YJ, Kim SR, Ki M.

Int J Hematol. 2003 Aug;78(2):133-8.

PMID:
12953807
9.

Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.

Konoplev S, Medeiros LJ, Lennon PA, Prajapati S, Kanungo A, Lin P.

Cancer. 2007 Oct 1;110(7):1520-6.

10.

Hematopoietic growth factors in the treatment of acquired bone marrow failure states.

Marsh JC, Ganser A, Stadler M.

Semin Hematol. 2007 Jul;44(3):138-47. Review.

PMID:
17631178
11.

Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, Gluckman E.

N Engl J Med. 1993 Oct 14;329(16):1152-7.

12.

[Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].

Xu HZ, Li A, Yu Y, Li JF, Liu X, Wang XH, Wang X, Xu GL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1308-11. Chinese.

PMID:
19099633
13.

Health care utilization and mortality among elderly patients with myelodysplastic syndromes.

Lindquist KJ, Danese MD, Mikhael J, Knopf KB, Griffiths RI.

Ann Oncol. 2011 May;22(5):1181-8. doi: 10.1093/annonc/mdq552. Epub 2010 Nov 1.

14.

Prognostic analysis of refractory anaemia in adult myelodysplastic syndromes.

Wang XQ, Chen ZX, Chen SC, Lin GW, Ji MR, Liang JY, Liu DD, Li DG, Ma Y.

Chin Med J (Engl). 2008 Sep 20;121(18):1787-91.

PMID:
19080358
15.

Clinical use of recombinant human G-CSF. Aplastic anemia (AA) and myelodysplastic syndromes (MDS).

Yoshida Y, Asano S, Hirashima K, Takaku F.

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:349-52. No abstract available.

PMID:
1284304
16.

Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia.

Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, Kiriyama Y, Akatsuka J, Tsukimoto I.

Blood. 1997 Aug 1;90(3):1009-13.

17.

Long-term follow-up of aplastic anaemia.

Narayanan MN, Geary CG, Freemont AJ, Kendra JR.

Br J Haematol. 1994 Apr;86(4):837-43.

PMID:
7918081
18.

Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death.

Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, Pizzo PA.

Medicine (Baltimore). 1992 Jan;71(1):24-43.

PMID:
1549057
19.

[Clinical study of GM-CSF in patients with aplastic anemia and myelodysplastic syndrome. (CSF39-300 Study Group)].

Kitamura K, Asano S, Mizoguchi H, Takaku F.

Rinsho Ketsueki. 1993 Dec;34(12):1540-9. Japanese.

PMID:
8295327
20.

Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis.

Kim KJ, Kwok SK, Park YJ, Kim WU, Cho CS.

Int J Rheum Dis. 2012 Feb;15(1):86-94. doi: 10.1111/j.1756-185X.2012.01704.x.

PMID:
22324951
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk